Viridian Therapeutics, Inc. · NASDAQ:VRDN

Commodore Capital LP's stake in Viridian Therapeutics, Inc. fell to 3.90% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Commodore Capital LP's stake in Viridian Therapeutics, Inc. fell to 3.90%, 3,200,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
3.90%
Shares
3,200,000
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Commodore Capital LP3.90%3,200,000
Commodore Capital Master LP3.90%3,200,000

Source

View original at SEC

Related